Prices are updated after-hours


Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date

symbols : LLY    save search

Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Published in Nature Communications
Published: 2022-06-28 (Crawled : 01:00) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 0.9% H: 0.78% C: -2.73%
INCY | News | $75.64 -2.22% 0.93% | twitter stocktwits trandingview |
Health Technology
| | O: -0.08% H: 0.0% C: 0.0%

ibi362 communications chinese diabetes results
Innovent Announces Phase 1b Study Results of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Published in Nature Communications
Published: 2022-06-29 (Crawled : 01:00) - prnewswire.com
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
INCY | News | $75.64 -2.22% 0.93% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

ibi362 communications chinese diabetes results
Akoya Biosciences to Partner with Acrivon Therapeutics for the Clinical Development of Acrivon’s Proprietary OncoSignature® Test into a Companion Diagnostic
Published: 2022-06-28 (Crawled : 12:20) - globenewswire.com
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 0.9% H: 0.78% C: -2.73%
AKYA | News | $12.61 4.73% 1.83% | twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 7.52% H: 4.77% C: 3.37%

oncosignature for test diagnostic therapeutics
DTx Pharma Appoints Peter Condon as Chief Business Officer
Published: 2022-06-28 (Crawled : 12:00) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 0.9% H: 0.78% C: -2.73%

pharma
Global Clinical Trials Markets 2022-2028: Globalization of Clinical Trials / Increasing R&D Promoting Outsourcing / Adoption of New Technology in Clinical Research
Published: 2022-06-28 (Crawled : 11:00) - prnewswire.com
ICLR | News | $219.14 -0.79% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 1.05% H: 0.96% C: -0.24%
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 0.9% H: 0.78% C: -2.73%
NVO | News | $108.3 -4.07% 2.17% | twitter stocktwits trandingview |
Health Technology
| | O: -2.98% H: 0.66% C: -0.87%

trials research technology
MSP Recovery Commences Billing Big Pharma More Than $5.6 Billion In Billed Amounts and More Than $2.8 Billion In Paid Amounts
Published: 2022-06-28 (Crawled : 02:00) - globenewswire.com
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -0.27% H: 0.06% C: -0.82%
ABBV | News | $152.49 -0.42% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 0.06% H: 1.27% C: -0.44%
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 0.9% H: 0.78% C: -2.73%

pharma
Lilly Declares Third-Quarter 2022 Dividend
Published: 2022-06-27 (Crawled : 21:00) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 1.32% H: 0.0% C: 0.0%


Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published: 2022-06-27 (Crawled : 16:00) - prnewswire.com
AZNCF | $127.2501 | twitter stocktwits trandingview |
Health Technology
| | O: -1.55% H: 4.43% C: 0.03%
NVS | $84.17 -1.3% 0.17% | twitter stocktwits trandingview |
Health Technology
| | O: 1.86% H: 1.05% C: 0.24%
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 1.32% H: 0.0% C: 0.0%
GSK | $43.35 -0.8% 0.19% | twitter stocktwits trandingview |
Health Technology
| | O: -0.16% H: 0.61% C: 0.18%
GLAXF | $21.99 | twitter stocktwits trandingview |
Health Technology
| | O: 0.47% H: 3.73% C: 3.73%
PFE | News | $50.66 -2.35% 0.4% | twitter stocktwits trandingview |
Health Technology
| | O: 1.46% H: 1.45% C: 0.78%
SPPI A | $0.8436 -1.91% 1.74% | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 2.28% C: -2.27%
SNYNF | News | $108.84 | twitter stocktwits trandingview |
Health Technology
| | O: 4.15% H: 0.0% C: 0.0%
BMY | $78.7 -1.6% 0.38% | twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 1.72% C: 0.95%
SNY | News | $52.13 -0.89% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 0.53% H: 0.0% C: 0.0%
AZN | $65.94 -0.86% 0.21% | twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 1.22% C: 0.38%

immunotherapy report therapy cancer market
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Published: 2022-06-27 (Crawled : 01:00) - prnewswire.com
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 1.32% H: 0.0% C: 0.0%
INCY | News | $75.64 -2.22% 0.93% | twitter stocktwits trandingview |
Health Technology
| | O: 3.36% H: 0.35% C: -0.71%

tyvyt treatment approval china
AC Immune Holds Annual General Meeting of Shareholders
Published: 2022-06-24 (Crawled : 21:00) - globenewswire.com
ACIU | $3.9 15.04% 0.0% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

meeting
Veru Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Published: 2022-06-24 (Crawled : 21:00) - globenewswire.com
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
VERU | $11.81 -8.17% -0.23% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

nasdaq grants
Psoriasis Treatment Market Players Observe Rising Trend of Personalized Medicines, According to TMR Report
Published: 2022-06-24 (Crawled : 12:00) - prnewswire.com
AZN | $65.94 -0.86% 0.21% | twitter stocktwits trandingview |
Health Technology
| | O: 4.41% H: 0.0% C: 0.0%
JNJ | News | $176.94 -2.84% 0.18% | twitter stocktwits trandingview |
Health Technology
| | O: 1.94% H: 0.0% C: 0.0%
PFE | News | $50.66 -2.35% 0.4% | twitter stocktwits trandingview |
Health Technology
| | O: 2.96% H: 0.0% C: 0.0%
AZNCF | $127.2501 | twitter stocktwits trandingview |
Health Technology
| | O: 0.64% H: 4.18% C: 1.33%
NVS | $84.17 -1.3% 0.17% | twitter stocktwits trandingview |
Health Technology
| | O: 2.38% H: 0.0% C: 0.0%
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 3.32% H: 0.0% C: 0.0%

treatment report psoriasis market
Ancora Heart Appoints Mark Miles as Chief Commercial Officer
Published: 2022-06-23 (Crawled : 13:20) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 4.14% H: 0.0% C: 0.0%

commercial heart miles
IconOVir Bio Appoints William Kaelin, Jr., M.D., to Board of Directors
Published: 2022-06-23 (Crawled : 13:20) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 4.14% H: 0.0% C: 0.0%


Orange Grove Bio Provides Corporate Update Highlighting Key Leadership Appointments and Establishment of New Academic Collaboration
Published: 2022-06-23 (Crawled : 12:00) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 4.14% H: 0.0% C: 0.0%

collaboration update
Novel T-Cell Immunotherapies Market - Future Pipeline/Clinical Trial Analysis and Revenue Forecast Snapshot - Exclusive Report by InsightAce Analytic
Published: 2022-06-23 (Crawled : 08:00) - prnewswire.com
TAK | $13.86 -1.42% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 1.56% H: 0.73% C: 0.44%
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 4.14% H: 0.0% C: 0.0%

report t-cell trial market
Delfi Diagnostics Appoints Jacob Van Naarden to its Board of Directors
Published: 2022-06-22 (Crawled : 13:00) - biospace.com/
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 1.31% H: 0.0% C: 0.0%

diagnostics
AVEO Oncology Announces Clinical Trial Collaboration and Supply Agreement with Eli Lilly and Company for ERBITUX® (cetuximab) in North America to Evaluate Ficlatuzumab and Cetuximab in Patients with Recurrent or Metastatic HNSCC
Published: 2022-06-22 (Crawled : 12:00) - investor.aveooncology.com
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 1.31% H: 0.0% C: 0.0%
AVEO | $6.36 -4.65% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 8.59% H: 9.93% C: 5.88%

erbitux america for collaboration trial agreement
Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-Line Treatment for Esophageal Squamous Cell Carcinoma
Published: 2022-06-21 (Crawled : 01:00) - prnewswire.com
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| | O: 1.03% H: 0.0% C: 0.0%
INCY | News | $75.64 -2.22% 0.93% | twitter stocktwits trandingview |
Health Technology
| | O: 5.74% H: 0.0% C: 0.0%

tyvyt treatment for approval china
The Worldwide Herpes Zoster Treatment Industry is Expected to Reach $303.4 Million by 2030
Published: 2022-06-20 (Crawled : 16:00) - prnewswire.com
BHC A | $8.83 1.73% 0.11% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
PPRUY | News | $52.24 | twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist
ABT | News | $106.97 -1.93% -0.11% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
PPRUF | News | $534.0 | twitter stocktwits trandingview |
Consumer Non-Durables
| Email alert Add to watchlist
GSK | $43.35 -0.8% 0.19% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
LLY | News S | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist
GLAXF | $21.99 | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

treatment expected
Your saved searches
Save your searches and get alerts when important news are released.

Mentioned Today
ACN | News | $283.8 -3.01% 0.07% | twitter stocktwits trandingview |
Technology Services

BTG | News | $3.56 -2.73% 0.84% | twitter stocktwits trandingview |
Non-Energy Minerals

DELL | News | $48.94 -2.59% 0.0% | twitter stocktwits trandingview |
Electronic Technology

GLPI | News 0 d | $46.68 -0.09% 0.0% | twitter stocktwits trandingview |
Finance

INCY | News | $75.64 -2.22% 0.93% | twitter stocktwits trandingview |
Health Technology

JTEKF | News | $ 0% | twitter stocktwits trandingview |
Producer Manufacturing

JTEKY | News | $24.29 | twitter stocktwits trandingview |
Manufacturing

LEA | News | $134.75 0.57% 0.0% | twitter stocktwits trandingview |
Producer Manufacturing

LLY | News 4 | $317.62 -2.95% -0.03% | twitter stocktwits trandingview |
Health Technology

NDAQ | News 4 | $154.64 -2.08% -0.23% | twitter stocktwits trandingview |
Finance

PPRUF | News | $534.0 | twitter stocktwits trandingview |
Consumer Non-Durables

PPRUY | News | $52.24 | twitter stocktwits trandingview |
Manufacturing